188P Single-cell and spatial transcriptomics delineate the microstructure and immune landscape of intrahepatic cholangiocarcinoma in the leading-edge area
Background: Currently anti-PD(L)1 immunotherapy is widely used to treat microsatellite-instability-high (MSI-H) pan-cancers.However, part of MSI-H patients and more others with microsatellite stable (MSS) phenotype do not respond well to this immunotherapy, which means potential extra factors or signals have also participated in the complicated tumor microevironment.
Authors
- Zhong Li (ORCID: https://orcid.org/0000-0002-1039-7000)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2024.100941
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00